Publications by authors named "Florence Wilson"

Claim this Profile
R
Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review.
Benjamin Derman, Carlyn Tan, Ian Steinfield, Florence R Wilson, Dee Lin

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta.
Gavin Y Oudit, Pronabesh DasMahapatra, Nicole Lyn, Florence R Wilson, Adekemi Adeyemi

Front Cardiovasc Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending the SUSI peatland simulator to include dissolved organic carbon formation, transport and biodegradation - Proper water management reduces lateral carbon fluxes and improves carbon balance.
Marjo Palviainen, Jukka Pumpanen, Virginia Mosquera, Eliza Maher Hasselquist, Hjalmar Laudon, Florence Renou Wilson

Sci Total Environ· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer.
Raj Hanvesakul, Badri Rengarajan, Navit Naveh, Anne Boccuti, Julie E Park, Florence R Wilson

J Comp Eff Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.
Josephine Louella Feliciano, Dylan McLoone, Yingxin Xu, Ruben G W Quek, Andreas Kuznik, Florence R Wilson

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.
Nick Freemantle, Yingxin Xu, Florence R Wilson, Patricia Guyot, Chieh-I Chen

Ther Adv Med Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50.
Andreas Kuznik, Caitlin Smare, Chieh-I Chen, Meena Venkatachalam, Sam Keeping, Florence Wilson

Value Health· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer.
Sam T Keeping, Shannon Cope, Keith Chan, Florence R Wilson, Jeroen P Jansen

J Comp Eff Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukaemia in COVID-19.
Robert Vardanyan, Arian Arjomandi Rad, Florence Wilson

Int J Lab Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquisition of antimicrobial-resistant bacteria in the absence of antimicrobial exposure: A systematic review and meta-analysis.
Erika M C D'Agata, Sara F Geffert, Rebecca McTavish, Florence Wilson, Chris Cameron

Infect Control Hosp Epidemiol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequence network meta-analysis in Crohn's disease: a methodological case study.
Abhishek Varu, Florence R Wilson, Peter Dyrda, Maureen Hazel, Brian Hutton

Curr Med Res Opin· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis.
Florence R Wilson, Megan E Coombes, Christine Brezden-Masley, Mariya Yurchenko, Quinlan Wylie

Syst Rev· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis.
Chris Cameron, Emmanuel Ewara, Florence R Wilson, Abhishek Varu, Peter Dyrda

Med Decis Making· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.
Florence R Wilson, Abhishek Varu, Debanjali Mitra, Chris Cameron, Shrividya Iyer

Breast Cancer Res Treat· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.
Florence R Wilson, Megan E Coombes, Quinlan Wylie, Mariya Yurchenko, Christine Brezden-Masley

Syst Rev· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
Angus Ho, Florence R Wilson, Stephanie L Peragine, Kajaparan Jeyanthan, Taylor R H Mitchell

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cells.
Florence R Wilson, Angus Ho, John R Walker, Xu-Dong Zhu

J Cell Sci· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylated (pT371)TRF1 is recruited to sites of DNA damage to facilitate homologous recombination and checkpoint activation.
Megan McKerlie, John R Walker, Taylor R H Mitchell, Florence R Wilson, Xu-Dong Zhu

Nucleic Acids Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis